Cannabis Report
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/11/2018 2:44:55 PM - Followers: 102 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

yes November 8, 2016  yes

From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Statement of Changes in Beneficial Ownership (4) 09/05/2018 08:00:28 AM
CLDX News: Statement of Changes in Beneficial Ownership (4) 08/28/2018 07:36:21 AM
CLDX News: Quarterly Report (10-q) 08/08/2018 04:10:27 PM
CLDX News: Current Report Filing (8-k) 08/08/2018 04:03:15 PM
CLDX News: Celldex Provides Corporate Update and Reports Second Quarter 2018 Results 08/08/2018 04:01:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#1658   Lets finally get this junk to .25 an harry crumb 09/11/18 02:44:55 PM
#1657   * * $CLDX Video Chart 08-22-18 * * ClayTrader 08/22/18 04:27:15 PM
#1656   Lets get this junk to .25 an be harry crumb 08/16/18 09:57:14 PM
#1655   Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates ProfitScout 08/13/18 10:15:14 AM
#1654   $CLDX Not responding well to earnings earlier, despite THREE-DAY-TRADER 08/09/18 12:52:41 PM
#1653   Celldex Provides Corporate Update and Reports Second Quarter ProfitScout 08/08/18 05:55:18 PM
#1652   I've been specifically speaking about Risk or earnings THREE-DAY-TRADER 08/07/18 02:39:32 PM
#1651   It´s mostly a gamble in such biotechs imo Klinsmann 08/07/18 02:36:03 PM
#1650   I just would not trust $CLDX in this THREE-DAY-TRADER 08/07/18 02:33:54 PM
#1649   The good part (which makes it a solid Klinsmann 08/07/18 12:46:11 PM
#1648   Yes, it is showing some stability since low THREE-DAY-TRADER 08/07/18 12:37:11 PM
#1647   Could be time to re-enter again as it Klinsmann 08/07/18 12:11:39 PM
#1646   I warned about this deteriorating since I stopped THREE-DAY-TRADER 08/02/18 10:43:38 PM
#1645   Still on watch, maybe times gonna change into Klinsmann 08/02/18 01:21:02 PM
#1644   Celldex to Report Second Quarter 2018 Financial Results ProfitScout 08/02/18 10:29:42 AM
#1643   Looking good to .25! Keep shorting here, every harry crumb 08/01/18 04:52:34 PM
#1642   4 weeks, this is .25! Wwweeeeee harry crumb 07/30/18 12:37:21 AM
#1641   Been telling people its junk and wont go harry crumb 07/28/18 11:58:52 AM
#1640   Starting to show worsening signs since 7/23 all THREE-DAY-TRADER 07/24/18 12:36:39 PM
#1639   Celldex Therapeutics (NASDAQ: CLDX) was founded based on ProfitScout 07/24/18 09:43:22 AM
#1638   Cldx will never c $1 again without the harry crumb 07/23/18 05:21:56 PM
#1637   Still on watch. Going to have its days imo... Klinsmann 07/19/18 04:33:21 PM
#1636   $CLDX ~ Still Holding over .50+ since late THREE-DAY-TRADER 07/19/18 03:39:12 PM
#1635   There is a convincing reason to buy: Celldex ProfitScout 07/16/18 08:13:40 PM
#1633   Exactly! Going to short this on 100k investment harry crumb 07/13/18 04:01:44 PM
#1632   They have until November to get re-listed if cash4me2 07/12/18 11:22:12 PM
#1631   Worthless pos company, not even worth 3 day harry crumb 07/10/18 01:36:28 PM
#1630   What and when is the next news catalyst cash4me2 07/06/18 11:32:32 PM
#1629   $CLDX ~ Yes -- recently acquired a position THREE-DAY-TRADER 07/05/18 08:14:48 AM
#1628   An just who do you think is going harry crumb 07/03/18 11:50:11 AM
#1627   Tons of bid whacking due to the short Chunky Salsa 07/03/18 10:25:44 AM
#1626   100% agree with you. I see accumulation on Chunky Salsa 07/03/18 09:12:44 AM
#1625   Celldex Therapeutics (CLDX): Stock Overview ProfitScout 07/03/18 09:06:23 AM
#1624   This like many comparable other biotechs gonna have Klinsmann 07/03/18 07:53:04 AM
#1623   This junk isnt even worth a 3 day harry crumb 07/03/18 07:40:31 AM
#1621   Junk! Not going any higher. Theres nothing positive harry crumb 07/02/18 07:27:13 PM
#1620   As of today it looks like it is THREE-DAY-TRADER 07/02/18 03:30:33 PM
#1619   .25 in 2 weeks if they dont r/s harry crumb 06/29/18 10:41:26 PM
#1618   It's holding above .48 took an initial position Chunky Salsa 06/29/18 12:05:03 PM
#1617   My chart reading says new lows and no stockboy 06/26/18 03:50:58 PM
#1616   Celldex Therapeutics, Inc. (CLDX) Analyst Opinion ProfitScout 06/26/18 12:03:42 PM
#1615   On its way to .25 then pow, reverse harry crumb 06/26/18 11:45:20 AM
#1614   * * $CLDX Video Chart 06-25-18 * * ClayTrader 06/25/18 04:49:04 PM
#1613   10,144,262 share Buy at close of the day THREE-DAY-TRADER 06/22/18 04:26:19 PM
#1612   Junk! Going to .25 before RS, then it harry crumb 06/22/18 08:24:24 AM
#1611   I have been out. Did not like the conix 06/21/18 04:18:21 PM
#1610   It just broke the lowest of the lows. stockboy 06/21/18 04:14:49 PM
#1609   Pretty modes investment. About $10,000. But better than nothing. conix 06/21/18 10:28:07 AM
#1608   It's always good when insiders are buying at stockboy 06/20/18 03:43:28 AM
#1607   Zacks Investment Research, Inc. upgrades CELLDEX THERAPEUTICS INC stockboy 06/20/18 03:36:20 AM